Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Botanix Pharmaceuticals Ltd (BOT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.245 +0.010    +4.26%
07:04:59 - Closed. Currency in AUD ( Disclaimer )
  • Volume: 4,067,914
  • Bid/Ask: 0.240 / 0.245
  • Day's Range: 0.235 - 0.245
Type:  Equity
Market:  Australia
ISIN:  AU000000BOT2 
Botanix Pharma 0.245 +0.010 +4.26%

BOT Recent Sentiments

 
User's sentiments regarding Botanix Pharma shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect BOT shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Botanix Pharma.
Start Date Username Call Open Rate End Date Chg. %
Dec 29, 2023 Craig Kirby   0.185 Jan 19, 2024 @ 0.175 -5.41%
Dec 27, 2023 Abdülkadir Erdönmez   0.165 Jan 01, 2024 @ 0.190 +15.15%
Oct 18, 2023 Jason Savage   0.135 Nov 30, 2023 @ 0.165 -22.22%
May 01, 2023 Pedro Opitz   0.088 May 09, 2023 @ 0.082 +6.82%
Mar 22, 2022 Mick Fabik   0.076 Mar 28, 2022 @ 0.078 +2.63%
Jan 16, 2022 adam gillick   0.081 Jan 17, 2022 @ 0.077 -4.94%
Oct 11, 2021 Brent Leighton   0.067 Nov 05, 2021 @ 0.064 -4.48%
Jul 20, 2021 Sajith Sreedharan   0.076 Aug 13, 2021 @ 0.078 +2.63%
Mar 24, 2021 Guillermo Portillo   0.105 Apr 16, 2021 @ 0.093 -11.43%
Feb 23, 2021 Guillermo Portillo   0.115 Mar 20, 2021 @ 0.115 0.00%
Jan 21, 2021 Guillermo Portillo   0.175 Feb 13, 2021 @ 0.140 -20.00%
Oct 13, 2020 Michael Kantanis   0.102 Nov 06, 2020 @ 0.091 +10.78%
Sep 29, 2020 Mark Mcdade   0.110 Oct 23, 2020 @ 0.100 -9.09%
May 19, 2020 Hermann Albrecht   0.043 May 22, 2020 @ 0.045 +4.65%
Apr 29, 2020 Abhishek Prasad   0.046 May 22, 2020 @ 0.045 -2.17%
Apr 24, 2020 Hermann Albrecht   0.057 May 15, 2020 @ 0.042 -26.32%
Apr 07, 2020 Sam Sawtell   0.050 May 01, 2020 @ 0.045 -10.00%
Mar 03, 2020 Flex Friday   0.077 Mar 27, 2020 @ 0.023 -70.13%
Feb 18, 2020 Sajith Sreedharan   0.090 Mar 13, 2020 @ 0.072 +20.00%
Nov 26, 2019 Sajith Sreedharan   0.105 Dec 21, 2019 @ 0.084 +20.00%
Oct 21, 2019 David Lien   0.250 Nov 15, 2019 @ 0.110 -56.00%
Oct 03, 2019 Sajith Sreedharan   0.237 Oct 25, 2019 @ 0.115 +51.48%
Sep 13, 2019 Chris Melder   0.260 Sep 30, 2019 @ 0.250 -3.85%
Jul 30, 2019 Raelene Watkins   0.260 Aug 23, 2019 @ 0.205 -21.15%
Jul 25, 2019 Sajith Sreedharan   0.260 Aug 01, 2019 @ 0.240 +7.69%
Jul 24, 2019 Fouad El Khoury   0.250 Aug 16, 2019 @ 0.225 -10.00%
Mar 20, 2019 Jack Li   0.110 Apr 13, 2019 @ 0.105 +4.55%
Mar 13, 2019 Jack Braddon   0.115 Apr 05, 2019 @ 0.110 -4.35%
Dec 06, 2018 Jack Li   0.079 Jan 05, 2019 @ 0.044 -44.30%
Aug 31, 2018 Virginia Campbell   0.105 Sep 30, 2018 @ 0.098 -6.67%
Jun 26, 2018 Serban Zahari   0.115 Jul 26, 2018 @ 0.100 -13.04%
Jan 23, 2018 Dean Herbert   0.130 Feb 22, 2018 @ 0.115 -11.54%
Dec 20, 2017 Virginia Campbell   0.060 Jan 19, 2018 @ 0.097 +61.67%
Dec 12, 2017 nader kassan   0.059 Jan 11, 2018 @ 0.081 +37.29%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BOT Price Commentary

Write your thoughts about Botanix Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email